Oncolytics Biotech, Inc.

Oncolytics Biotech, Inc.

Sector: Noncommercial Research Organizations Region: Canada

: | Toronto Stock Exchange: ONC | Nasdaq: ONCY

Oncolytics Biotech, Inc. is a biotechnology company that is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. Its clinical program includes a variety of human trials, including a phase III trial in head and neck cancers using Reolysin, which is a proprietary formulation of the human reo-virus. The company was founded by Matthew C. Coffey on April 2, 1998 and is headquartered in Calgary, Canada.

News & Analysis

You may also be interested in: